Andrew C. Haller, Ph.D. - Publications

Affiliations: 
2013 Roswell Park . Pharmacology State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Cell Biology, Molecular Biology, Oncology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Haller AC, Tan W, Payne-Ondracek R, Underwood W, Tian L, Morrison C, Li F. High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy. The Prostate. 74: 509-19. PMID 24375440 DOI: 10.1002/Pros.22770  0.594
2012 Cheng Q, Ling X, Haller A, Nakahara T, Yamanaka K, Kita A, Koutoku H, Takeuchi M, Brattain MG, Li F. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. International Journal of Biochemistry and Molecular Biology. 3: 179-97. PMID 22773958  0.387
2012 Haller AC, Morrison C, Tan W, Payne-Ondracek R, Underwood W, Poch M, Tian L, Mohler J, Li F. Abstract 3637: Loss of prostate derived Ets (E-twenty six) transcription factor (PDEF) predicts patients at the highest risk of metastatic prostate cancer Cancer Research. 72: 3637-3637. DOI: 10.1158/1538-7445.Am2012-3637  0.582
2012 haller AC, Li F. Abstract 2871: Inhibition of androgen receptor-mediated expression of prostate derived ets transcription factor (PDEF) induces a loss of prostate cancer cell differentiation Cancer Research. 72: 2871-2871. DOI: 10.1158/1538-7445.Am2012-2871  0.601
2011 Haller AC, Morrison C, Payne-Ondracek R, Tan W, Tian L, Mohler J, Li F. Abstract 4173: Prostate derived Ets (E-twenty six) transcription factor (PDEF) as a prognostic biomarker for metastatic prostate cancer Cancer Research. 71: 4173-4173. DOI: 10.1158/1538-7445.Am2011-4173  0.58
Show low-probability matches.